Tevogen Bio amends Bylaws to modify director resignation procedure for majority vote failures

Tevogen Bio Holdings Inc.

Board amended Bylaws on April 21, 2025 to alter process for director resignations when director fails to receive majority vote in uncontested election.
Amendment filed as Exhibit 3.1; no other changes to Bylaws or fiscal year announced.
Procedural governance amendment with no immediate financial or operational impact.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tevogen Bio Holdings Inc.: Amended Bylaws to modify procedure for deciding on director resignation after failed majority vote in uncontested election (effective 2025-04-21).

Change: bylaw amendment
Effective: 2025-04-21

Exact text from the filing

On April 21, 2025, the Board of Directors of Tevogen Bio Holdings Inc. (the “Company”) amended the Bylaws of the Company (as so amended and restated, the “Bylaws”) to modify the procedure for making a decision regarding a resignation tendered by a director who fails to receive a majority of votes cast in an uncontested election.

View on SEC.gov

24 governance changes filed in the last 30 days. Browse all governance changes →

Tevogen Bio Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-006227

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.